NRX — Noronex Share Price
0.000.00%
Last trade - 00:00- AU$7.25m
- AU$6.78m
- AU$0.01m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.76 | ||
| Price to Tang. Book | 8.76 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3,715.62 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -393.65% | ||
| Return on Equity | -174.1% | ||
| Operating Margin | -174416.41% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | n/a | 0 | 0.01 | 0.02 | 0.01 | n/a | n/a | -15.77% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Noronex Limited is an Australia-based copper explorer company, which is focused on Kalahari Copper Belt, Namibia and Botswana, and in Ontario, Canada. Its exploration package spans approximately 9,789 square kilometers (km2) across the prospective but under-explored Kalahari Copper Belt, which extends from central Namibia to northern Botswana. The tenements contain 300 km of strike length targeting the key NPF-D’Kar formation contact point where copper deposits occur in the Kalahari Copper Belt. Its other projects include Etango North Uranium Project, Witvlei Project, The Onaman Project (Ontario Copper Project), Humpback Fiesta Project, and Humpback-Damara Project. The Onaman Project is a Cu-Au-Ag project with a joint ore reserves committee (JORC) (2012) compliant resource. The Onaman Project is located on the Onaman-Tashota Greenstone Belt. The Company also has exposure to a uranium tenement in the center of Namibia’s hard rock uranium district.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 1st, 2015
- Public Since
- November 15th, 2017
- Sector
- Metals & Mining
- Industry
- Basic Materials
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 499,687,401
- Address
- Suite 1, 295 Rokeby Road, SUBIACO, 6008
- Web
- https://noronexlimited.com.au/
- Phone
- +61 865552950
- Auditors
- HLB Mann Judd
Upcoming Events for NRX
Similar to NRX
29Metals
Australian Stock Exchange - SEATS
5E Advanced Materials
Australian Stock Exchange - SEATS
Abarta Resources
Australian Stock Exchange - SEATS
ABx
Australian Stock Exchange - SEATS
Accelerate Resources
Australian Stock Exchange - SEATS
FAQ
What is the Noronex share price?
As of Today at 22:20 UTC, shares in Noronex are trading at AU$0.01. This share price information is delayed by 15 minutes.
How has the Noronex share price performed this year?
Shares in Noronex last closed at AU$0.01 and the price had moved by -3.33% over the past 365 days. In terms of relative price strength the Noronex share price has underperformed the ASX All Ordinaries Index by -9.9% over the past year.
What are the analyst and broker recommendations for Noronex?
There is no consensus recommendation for this security.
Find out moreWhat is the Noronex dividend yield?
Noronex does not currently pay a dividend.
Does Noronex pay a dividend?
Noronex does not currently pay a dividend.
When does Noronex next pay dividends?
Noronex does not currently pay a dividend.
How do I buy Noronex shares?
To buy shares in Noronex you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Noronex?
As of the previous close price of AU$0.01, shares in Noronex had a market capitalisation of AU$7.25m.
Where are Noronex shares listed?
Here are the trading details for Noronex:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: NRX
What kind of share is Noronex?
Based on an overall assessment of its quality, value and momentum Noronex is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Noronex share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Noronex share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Noronex. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -32.31%.
As of the last closing price of AU$0.01, shares in Noronex were trading +1.15% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Noronex PE Ratio?
The Noronex PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Noronex?
Noronex's management team is headed by:
- David Prentice - NEC
- James Thompson - EDR
- Sebastian Andre - SEC
- Robert Klug - NID
- Piers Lewis - NID